Merck's Keytruda helps lung cancer patients live longer in trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/21/2026

1. TGT
2. EL
3. SPY
4. WMT
5. ADI
6. ROST
7. BILL
8. MRNA
9. MRK
10. COTY

Go back to Merck's Keytruda helps lung cancer patients live longer in trial
ASTRAZENECA PLC (NASDAQ: AZN) Delayed: 92.77 --0 (-0%)
Previous Close $92.77    52 Week High $35.04 
Open $92.77    52 Week Low $26.97 
Day High $92.77    P/E N/A 
Day Low $92.77    EPS $0.00 
Volume 5,094,210       

Bristol-Myers Squibb (NYSE: BMY) Delayed: 65.47 -2.14 (3.17%)
Previous Close $67.61    52 Week High $77.12 
Open $67.22    52 Week Low $49.03 
Day High $67.54    P/E 42.51 
Day Low $65.45    EPS $1.54 
Volume 9,489,476       

Merck & Co. (NYSE: MRK) Delayed: 148.99 -3.21 (2.11%)
Previous Close $152.20    52 Week High $65.46 
Open $150.78    52 Week Low $47.97 
Day High $152.52    P/E 101.35 
Day Low $148.52    EPS $1.47 
Volume 16,441,653